A Randomized Pilot Trial of the Donor Conception Tool to Empower Parental Telling and Talking (TELL Tool) with Their Children About Their Genetic Origins
Patricia E. Hershberger PhD, APRN, FNP-BC, FAAN, Valerie Gruss PhD, APRN, NP-BC, FAAN, Alana D. Steffen PhD, Kirby Adlam PhD, APRN-FPA, CNM, FACNM, Martha Driessnack PhD, PNP, RN, Harold D. Grotevant PhD, Susan C. Klock PhD, Lauri A. Pasch PhD, Ruchi Bhagat PhD, Agatha M. Gallo PhD, RN, FAAN
{"title":"A Randomized Pilot Trial of the Donor Conception Tool to Empower Parental Telling and Talking (TELL Tool) with Their Children About Their Genetic Origins","authors":"Patricia E. Hershberger PhD, APRN, FNP-BC, FAAN, Valerie Gruss PhD, APRN, NP-BC, FAAN, Alana D. Steffen PhD, Kirby Adlam PhD, APRN-FPA, CNM, FACNM, Martha Driessnack PhD, PNP, RN, Harold D. Grotevant PhD, Susan C. Klock PhD, Lauri A. Pasch PhD, Ruchi Bhagat PhD, Agatha M. Gallo PhD, RN, FAAN","doi":"10.1016/j.pedhc.2024.06.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Parents who use donated gametes or embryos to form their families struggle with telling their children about their genetic origins. We developed the Tool to Empower Parental Telling and Talking (TELL Tool) to support parents in disclosure to their children and an eBook attention control.</div></div><div><h3>Method</h3><div>A randomized parallel, two-group, attention-controlled clinical pilot trial was conducted online during COVID-19. Feasibility, acceptability, and preliminary effects among parents with children aged 1–16 years were examined.</div></div><div><h3>Results</h3><div>Over 10 months, our target of 75 parents were enrolled (85% of eligible [95% confidence interval (CI), 76% to 91%]), and 68% (95% CI: 57% to 78%) were retained at 12 weeks. At 4 and 12 weeks, positive trends were found for parental disclosure, telling confidence, and anxiety compared with attention controls.</div></div><div><h3>Discussion</h3><div>The study protocol is feasible, and the TELL Tool is acceptable to parents and demonstrates a positive effect on parents’ ability to tell their children. The results support the implementation of a large efficacy trial.</div></div>","PeriodicalId":50094,"journal":{"name":"Journal of Pediatric Health Care","volume":"39 2","pages":"Pages 175-188"},"PeriodicalIF":1.8000,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Health Care","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0891524524001494","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Parents who use donated gametes or embryos to form their families struggle with telling their children about their genetic origins. We developed the Tool to Empower Parental Telling and Talking (TELL Tool) to support parents in disclosure to their children and an eBook attention control.
Method
A randomized parallel, two-group, attention-controlled clinical pilot trial was conducted online during COVID-19. Feasibility, acceptability, and preliminary effects among parents with children aged 1–16 years were examined.
Results
Over 10 months, our target of 75 parents were enrolled (85% of eligible [95% confidence interval (CI), 76% to 91%]), and 68% (95% CI: 57% to 78%) were retained at 12 weeks. At 4 and 12 weeks, positive trends were found for parental disclosure, telling confidence, and anxiety compared with attention controls.
Discussion
The study protocol is feasible, and the TELL Tool is acceptable to parents and demonstrates a positive effect on parents’ ability to tell their children. The results support the implementation of a large efficacy trial.
期刊介绍:
The Journal of Pediatric Health Care, the official journal of the National Association of Pediatric Nurse Practitioners, provides scholarly clinical information and research regarding primary, acute and specialty health care for children of newborn age through young adulthood within a family-centered context. The Journal disseminates multidisciplinary perspectives on evidence-based practice and emerging policy, advocacy and educational issues that are of importance to all healthcare professionals caring for children and their families.